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Abstract
Obesity is a risk factor for several aging-related diseases such as type 2 diabetes, cardiovascular disease, and cancer.
Especially, cardiovascular disease is triggered by obesity by inducing vascular senescence and chronic low-grade
systemic inflammation, also known as inflamm-aging. Released molecules from damaged cells and their recognition
by the innate immune system is one of the mechanisms driving inflamm-aging. Obesity results in mitochondrial
damage, leading to endothelial inflammation triggered by cytosolic mtDNA via the cGAS/STING pathway. Recently,
we have shown STING SNP R293Q to be associated with a decreased risk for aging-related diseases in current
smokers. Since current smoking triggers DNA damage that, similar to obesity, may result in the release of DNA into
the cytoplasm, we hypothesized that the cGAS/STING pathway can modify the phenotype of aging also in obese
subjects. Therefore, the objective of our study was to investigate whether STING R293Q is associated with aging-
related diseases in obese individuals. We indeed show that STING 293Q is associated with protection from
combined aging-related diseases (P = 0.014) and, in particular, cardiovascular disease in these subjects (P = 0.010).
Therefore, we provide the first evidence that stratification for obesity may reveal new genetic loci determining the
risk for aging-related diseases.
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Background
Aging is a complex process characterized by a continu-
ous loss of physiological integrity, resulting in the onset
of aging-related pathologies, e.g. cardiovascular disease
(CVD), cancer, type 2 diabetes (DM-T2), chronic lung
diseases, and cognitive impairment. Among them, CVD
is worldwide the most frequent cause of mortality [1].
Several hallmarks of aging have been proposed by
Lopez-Otin et al. [2], including genomic DNA instability,
altered intercellular communication, and mitochondrial
dysfunction. The DNA damage is known for a long time
to be associated with aging-related pathologies [3]. Sev-
eral premature aging syndromes, such as Hutchinson-
Gilford Progeria syndrome, are driven by the enhanced
DNA damage, accompanied by the release of genomic
DNA into the cytoplasm [4]. An important aspect of al-
tered cellular communication accompanying aging in
mammals is inflamm-aging, a condition of systemic
chronic low-grade inflammation [5]. Inflamm-aging is
well known to be associated with aging-related diseases
[6] and may result from the accumulation of tissue dam-
age, cell-free or cytosolic DNA, and cellular senescence.
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Senescent cells accumulate with age and secrete inflam-
matory cytokines by entering the secretory-associated
phenotype [5, 7]. Mitochondrial dysfunction and the re-
lease of increased amounts of free radicals (free radical
theory) have also been supposed to trigger aging [8].
However, also other mechanisms of mitochondrial dys-
function have been discussed to be involved in aging [9].
Plasma levels of free mitochondrial DNA (mtDNA) in-
creases with age and are associated with inflamm-aging
[10]. Cytoplasmic mtDNA released from dysfunctional
mitochondria fuel inflamm-aging via innate immune
receptors [11].
Obesity is an important risk factor for several aging-
related diseases. In particular, CVD and DM-T2 are trig-
gered by obesity-induced chronic low-grade inflamma-
tion [12]. For CVD, obesity is one of the most important
risk factors [13] and has also been shown to be associ-
ated with endothelial senescence [14]. Recently, it has
been demonstrated in mice model that free fatty acid
diet induces mitochondrial damage, resulting in the re-
lease of mtDNA into the cytosol, triggering endothelial
inflammation and insulin resistance by activation of the
cGAS/STING pathway [15]. Notably, STING is a key in-
nate immune receptor involved in DNA sensing and
plays a pivotal role in both innate immune sensing of
pathogens and senescence. Innate immune signaling via
cGAS/STING promotes senescence through the secre-
tion of inflammatory cytokines and chemokines, trigger-
ing the process of inflamm-aging. In addition, cGAS, as
well as STING KO mice, exhibit a reduced senescence-
associated secretory phenotype (SASP) upon irradiation
compared to Wt mice [16, 17].
PolSenior is a multicenter, interdisciplinary project de-
signed to assess the health and socio-economic status of
Polish Caucasians aged ≥65 years [18]. By genotyping par-
ticipants of this program, we showed previously that the
STING 293Q allele (rs7380824) is associated with protec-
tion from aging-related diseases in a subgroup of current
smokers, leading to the hypothesis that the decreased sen-
sitivity of innate immune receptors, by lowering the
process of inflamm-aging, may be associated with healthy
aging. We postulated that cytoplasmic DNA induced by
genotoxic effects of smoking possibly stimulates the
process of inflamm-aging via STING, which is decreased
by the less functional 293Q allele [19]. To analyze whether
STING 293Q allele has a similar effect on aging-related
diseases in obese subjects we excluded all current smokers
and analyzed only sub-cohorts of obese (N = 931, body
mass index (BMI) ≥30 kg/m2) and non-obese (N = 1948,
BMI < 30 kg/m2) subjects. We could show here that this
allele is also associated with protection from aging-related
diseases, P = 0.014, in these subjects. This effect is more
pronounced for CVD, P = 0.010, and supports our hypoth-
esis of less inflamm-aging by mutations in innate immune
receptors being protective regarding aging-related
diseases.
Common risk factors for aging-related diseases in the
study cohort
First, we analyzed the distribution of common risk fac-
tors for aging-related diseases among obese and non-
obese subjects. Since we have shown previously that
among current smokers STING 293Q is strongly associ-
ated with the decrease in risk for aging-related diseases,
we excluded all these individuals from the present ana-
lysis. As shown in Table 1, age, sex, and former smoking
status differed significantly between both groups with
P < 0.001 for sex and age, and P = 0.007 for former
smokers. Therefore, subsequent calculations were cor-
rected for age, sex, and former smoking status. Next, we
determined the obesity-associated risk for aging-related
diseases by logistic regression analysis. As shown in
Table 2, obesity is a strong risk factor for combined
aging-related diseases (CVD + chronic lung disease +
cancer + DM-T2 + cognitive impairment): P < 0.001,
CVD: P = 0.015, chronic lung diseases: P = 0.018, and
DM-T2: P < 0.001. Obesity is well known to be a strong
risk factor for CVD and DM-T2 [12], and our results are
consistent with this observation. In our cohort, no sig-
nificant association with cancer and cognitive impair-
ment could be observed.
Table 1 Baseline characteristics of obese and non-obese
subjects





Mean age (SD) 80.3 (8.4) 76.5 (7.7) < 0.001
Male/female 1077/871 367/564 < 0.001
Former smoking yes/no 790/1158 329/602 0.007
P-values were determined by Student’s T-test for mean age and chi2-test for
sex and former smoking
Table 2 Analysis of the obesity-associated risk for aging-related
diseases
Diseases (N: cases/controls) P-value OR (95%CI)
Aging-related diseases (2009/810)* < 0.001 1.595 (1.323–1.925)
Cardiovascular disease (382/810) 0.015 1.405 (1.068–1.846)
Chronic lung disease (160/810) 0.018 1.579 (1.081–2.307)
Cancer (47/810) 0.362 0.709 (0.338–1.486)
DM-T2 (177/810) < 0.001 2.359 (1.667–3.338)
Cognitive impairment (343/810) 0.181 1.238 (0.905–1.694)
Analysis was done by logistic regression using SPSS Statistic software package
(version 20.0 IBM, Munich, Germany) with BMI < 30 kg/m2 as reference and
BMI ≥30 kg/m2 as predictor, and was corrected for age, sex and former
smoking. * 60 samples were excluded from the analysis due to the incomplete
disease record
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Inflammatory markers in obese subjects
Since obesity is well known to induce systemic chronic
low-grade inflammation, we next analyzed the influence
of BMI on the steady-state CRP and IL-6 levels. To ex-
clude subjects with current infections, all subjects with a
white blood cell count > 10.000/mm3 were removed from
this analysis. As shown in Table 3, the steady-state CRP
level is higher in the obese compared to non-obese sub-
jects, 4.93 μg/ml vs 4.32 μg/ml, P = 0.049 and is further
increased in class 2 obese subjects (BMI ≥35 kg/m2) up
to 5.72 μg/ml, P = 0.007. The increase in CRP level is in
line with the well-established role of chronic inflamma-
tion in obesity-induced pathologies [12]. However, in
our study group, the steady-state level for IL-6 exhibits
only a marginal, non-significant increase.
Effect of STING 293Q allele on aging-related diseases
We next determined the effect of STING 293Q allele on
the obesity-associated risk for aging-associated diseases.
Healthy controls (n = 810) having none of the five aging-
related diseases were compared to subjects having one
or more diseases. For the analysis of a given disease, sub-
jects with multiple diseases were excluded to rule out
trade-off effects. Therefore, patients suffering from one
given disease were compared to healthy subjects. We
show here for the first time that this allele is associated
with a decreased risk for obesity-associated combined
aging-related diseases with OR: 0.651 (95% CI: 0.462–
0.917) and P = 0.014. This effect is even stronger for
CVD with OR: 0.490 (95% CI: 0.285–0.841), and P =
0.010 (Table 4). The risk for chronic lung disease and
DM-T2 exhibits no significant association with STING
293Q, although obesity is a strong risk factor for both
diseases (Table 2), indicating the involvement of other
patho-mechanisms in these pathologies. Also, the risk
for cancer and cognitive impairment showed no associ-
ation with STING 293Q. No significant associations
were found in non-obese subjects.
Influence of STING 293Q allele on inflammatory markers
in obese subjects
Since we hypothesize that an impaired innate immune sig-
naling in the elderly may be associated with healthy aging,
we analyzed the effect of STING 293Q on CRP and IL-6
steady-state levels in obese subjects. In STING 293Q car-
riers, we found slightly reduced, however not significantly,
steady-state levels of both CRP and IL-6. The mean CRP
level is reduced from 5.11 μg/L to 4.41 μg/L, and the mean
IL-6 level is reduced from 3.30 ng/L to 2.98 ng/L in allele
carriers compared to non-carriers (Table 5). Although not
significant, these differences are well in line in with our hy-
pothesis of impaired innate immune signaling being protect-
ive regarding aging-related diseases due to the decreased
inflamm-aging. Furthermore, one may speculate that in
chronic settings, even slight differences in pro-inflammatory
markers may affect the risk for aging-related diseases.
Combined effect of STING 293Q in obese subjects and
current smokers
Since both conditions, obesity and smoking, may result
in an enhanced STING signaling due to the increased
cytosolic DNA content, we combined current smokers
and obese subjects and analyzed the effect of STING
293Q on aging-related diseases in this subgroup. As
Table 3 CRP and IL-6 baseline levels in obese and non-obese subjects
Mean CRP
(μg/ml)
STD P-value Mean IL-6
(ng/ml)
STD P-value
BMI < 30 kg/m2 (n = 1846)* 4.32 8.0 3.28 3.4
BMI ≥30 kg/m2 (n = 869)* 4.93 6.6 0.049 3.22 2.7 0.632
BMI ≥35 kg/m2 (n = 236)* 5.72 7.1 0.007 3.42 2.6 0.397
P-value was determined by Student’s T-test. * For some samples, data on the level of inflammatory markers were not available (n = 54). Samples with a white
blood cell count above 10,000/mm3 were excluded (n = 110)
Table 4 Analysis of STING 293Q allele effects on certain aging-
related diseases in obese subjects
Diseases (N: cases/controls) P-value OR (95%CI)
Aging-related diseases (683/231)* 0.014 0.651 (0.462–0.917)
CVD (127/231) 0.010 0.490 (0.285–0.841)
Chronic lung diseases (57/231) 0.062 0.492 (0.233–1.037)
Cancer (10/231) 0.529 0.601 (0.123–2.927)
DM-T2 (88/231) 0.375 0.776 (0.443–1.359)
Cognitive impairment (92/231) 0.554 0.835 (0.459–1.518)
Analysis was done by logistic regression using SPSS Statistic software package
(version 20.0 IBM, Munich, Germany) with STING R/R as reference and
combined R/Q and Q/Q genotypes as predictor, and correction for age, sex
and former smoking. * 17 samples were excluded from the analysis due to the
incomplete disease record
Table 5 CRP and IL-6 baseline levels in obese subjects are
slightly influenced by STING 293Q
STING Mean CRP
(mg/l)
STD P-value Mean IL-6
(ng/L)
STD P-value
R/R 5.11 7.1 0.093 3.30 2.8 0.098
R/Q + Q/Q 4.41 4.6 2.98 2.2
P-values were determined by Student’s T-test. Samples with a white blood cell
count above 10,000/mm3 were excluded
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shown in Table 6, STING 293Q is significantly associated
with protection from aging-related diseases, CVD, and
chronic lung diseases with P < 0.000, P= 0.002, and P=
0.023, respectively. For DM-T2 we only found a trend for
protection with P= 0.095. Of note, in case of cancer and cog-
nitive impairment, this association is far from being signifi-
cant; however, both OR are below 1, indicating a possible
significant association in larger cohorts.
Conclusion
GWAS for complex diseases have revealed a large num-
ber of associations; however, the expected heritability
could not be explained so far because the effect sizes are
almost modest, possibly due to rare variants or not in-
cluded gene-environment interactions [20]. Stratification
for specific lifestyle or environmental conditions may re-
veal additional important genetic variants. Genetic asso-
ciations with diseases that rely on specific gene-lifestyle
interactions have been described previously. Recently,
some new genetic loci that are associated with serum
lipids and CVD have been detected by a large meta-
analysis only after stratification for smoking status [21].
In addition, one variation on 2q12.1 locus has been
shown to be associated with blood pressure only in
obese subjects [22]. In concert with these findings, we
provide the first evidence that stratification for obesity
and smoking may reveal new genetic loci determining
the risk for aging-related diseases or CVD. However, our
work has several limitations. The first limitation is a
relatively low sample number and the inclusion of only
one ethnic group. On the other hand, however, this
group is well characterized in terms of morbidity and
other health-related parameters. Second, determination
of cytoplasmic mtDNA as well as circulating DNA and
correlation with STING 293Q and aging related diseases
would be very interesting. Therefore, further studies are
needed to confirm the protective effect of the STING
293Q allele.
The cGAS/STING pathway is well established to be a
key regulator of senescence by sensing DNA released
upon DNA damage [23]. Cigarette smoke is a genotoxic
agent inducing DNA damage [24]. In addition, also
obesity induces DNA damage [25] and, furthermore, free
fatty acids involved in obesity induce a release of
mtDNA into the cytoplasm [15]. Together with our re-
cent observation, we speculate that conditions such as
smoking or obesity, resulting in an enhanced release of
DNA, may fuel the process of aging in a STING-
dependent manner by augmenting senescence, endothe-
lial inflammation, and inflamm-aging (Fig. 1). Therefore,
STING variants that decrease the sensitivity of the in-
nate immune system towards endogenous DNA possibly
reduce the risk for aging-related diseases.
Personalized medicine, including SNP screening, pre-
dicting the risk for aging-related diseases, may also strat-
ify for personal environmental or lifestyle factors to
reduce the frequency of aging-related diseases. This
Table 6 Analysis of STING 293Q allele effects on certain aging-
related diseases in obese subjects and current smokers
Diseases (N: cases/controls) P-value OR (95%CI)
Aging-related diseases (885/346) < 0.000 0.567 (0.426–0.754)
CVD (157/346) 0.002 0.467 (0.291–0.749)
Chronic lung diseases (83/346) 0.023 0.495 (0.270–0.907)
Cancer (15/346) 0.397 0.573 (0.158–2.081)
DM-T2 (117/346) 0.095 0.660 (0.405–1.075)
Cognitive impairment (119/346) 0.289 0.758 (0.454–1.265)
Analysis was done by logistic regression using SPSS Statistic software package
(version 20.0 IBM, Munich, Germany) with STING R/R as reference and
combined R/Q and Q/Q genotypes as predictor and correction for age and sex
Fig. 1 A possible role for STING 293Q in protection from aging-related diseases. Both, smoking and obesity result in the increased DNA damage
that in turn results in STING activation and progression of senescence which may be reduced by STING 293Q
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individualized care of the elderly patient may reduce
mortality and health care cost overall.
Materials and methods
Study cohort
PolSenior is a multicenter interdisciplinary project de-
signed to assess the health and socio-economic status of
Polish Caucasians aged ≥65 years [18]. All participants
completed a detailed questionnaire, underwent an exam-
ination, including elements of comprehensive geriatric
assessment and donated blood for biochemical and gen-
etic analyses. All participants gave a written informed
consent for participation in the study. All investigations
were carried out in accordance with the ethical guide-
lines of the 1975 Declaration of Helsinki. The study was
approved by the Bioethics Commission of the Medical
University of Silesia in Katowice.
Statistics
Binary logistic regression analyses have been performed
employing the IBM SPSS Statistics software package
(version 20.0, IBM, Munich, Germany). Sex, age, and
smoking status were included as co-factors. Binary vari-
ables (sex and smoking) were analyzed by chi2-test, con-
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